IceCure Medical Free Cash Flow 2020-2025 | ICCM
IceCure Medical free cash flow from 2020 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| IceCure Medical Annual Free Cash Flow | |
|---|---|
| 2024 | -12.63 |
| 2023 | -13.03 |
| 2022 | -15.18 |
| 2021 | -13.14 |
| 2020 | -3.91 |
| 2019 | -2.09 |
| IceCure Medical Quarterly Free Cash Flow | |
|---|---|
| 2025-03-31 | -4.05 |
| 2024-12-31 | |
| 2024-03-31 | -2.88 |
| 2023-03-31 | -3.19 |
| 2022-03-31 | -3.20 |
| 2021-12-31 | |
| 2021-09-30 | -7.07 |
| 2021-06-30 | |
| 2021-03-31 | -1.91 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.051B | $0.003B |
| IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.515B | 26.35 |
| CVS Health (CVS) | United States | $84.516B | 10.51 |
| Elevance Health (ELV) | United States | $84.143B | 10.86 |
| Cencora (COR) | United States | $56.815B | 19.77 |
| Natera (NTRA) | United States | $23.263B | 0.00 |
| DiDi Global (DIDIY) | China | $22.732B | 24.15 |
| Labcorp Holdings (LH) | United States | $21.849B | 17.72 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.354B | 0.00 |
| CochLear (CHEOY) | Australia | $12.742B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.42 |
| ICON (ICLR) | Ireland | $11.895B | 11.06 |
| Revvity (RVTY) | United States | $11.192B | 19.26 |
| Viatris (VTRS) | United States | $10.387B | 3.57 |
| Avantor (AVTR) | United States | $9.152B | 13.30 |
| Medpace Holdings (MEDP) | United States | $8.871B | 23.56 |
| HealthEquity (HQY) | United States | $8.752B | 38.34 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.239B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.245B | 25.00 |
| BrightSpring Health Services (BTSG) | United States | $4.003B | 36.73 |
| Sotera Health (SHC) | United States | $3.148B | 17.89 |
| Alignment Healthcare (ALHC) | United States | $2.764B | 0.00 |
| Concentras Parent (CON) | United States | $2.689B | 15.54 |
| Surgery Partners (SGRY) | United States | $2.589B | 33.67 |
| Organon (OGN) | United States | $2.548B | 2.71 |
| GeneDx Holdings (WGS) | United States | $2.274B | 87.59 |
| PACS (PACS) | United States | $1.943B | 0.00 |
| Ardent Health (ARDT) | United States | $1.851B | 7.89 |
| Premier (PINC) | United States | $1.802B | 13.68 |
| Progyny (PGNY) | United States | $1.782B | 39.23 |
| GoodRx Holdings (GDRX) | United States | $1.675B | 33.50 |
| Teladoc Health (TDOC) | United States | $1.384B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.149B | 8.74 |
| Establishment Labs Holdings (ESTA) | $1.058B | 0.00 | |
| CareDx (CDNA) | United States | $1.055B | 16.48 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.811B | 7.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.650B | 0.00 |
| Nutex Health (NUTX) | United States | $0.649B | 9.83 |
| Embecta (EMBC) | United States | $0.574B | 3.87 |
| InnovAge Holding (INNV) | United States | $0.536B | 0.00 |
| Enhabit (EHAB) | United States | $0.470B | 38.67 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| SBC Medicals (SBC) | United States | $0.450B | 0.00 |
| Omada Health (OMDA) | $0.382B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.281B | 0.00 |
| Beauty Health (SKIN) | United States | $0.243B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.220B | 0.00 |
| Oncology Institute (TOI) | United States | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| So-Young (SY) | China | $0.168B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.130B | 0.00 |
| OncoCyte (IMDX) | United States | $0.105B | 0.00 |
| KindlyMD (NAKA) | United States | $0.098B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Biodesix (BDSX) | United States | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |